A novel mouse model for colitis-associated colon carcinogenesis induced by 1,2-dimethylhydrazine and dextran sulfate sodium

被引:12
作者
Wang, Jian-Guo [1 ]
Wang, Dong-Fei [1 ]
Lv, Bing-Jian [2 ]
Si, Jian-Min [1 ]
机构
[1] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Gastroenterol, Sch Med, Hangzhou 310016, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Pathol, Sch Med, Hangzhou 310016, Zhejiang, Peoples R China
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To develop an efficient animal colitis-associated carcinogenesis model and to detect the expression of beta-catenin and p53 in this new model. METHODS: Dysplasia and cancer were investigated in mice pretreated with a single intraperitoneal injection of 20 mg/kg body mass of 1,2-dimethylhydrazine prior to three repetitive oral administrations of 30 g/L dextran sulfate sodium to give conditions similar to the clinically observed active and remission phases. Immunohistochemical staining of beta-catenin and p53 was performed on paraffin-imbedded specimens of animals with cancer and/or dysplasia, those without dysplasia and the normal control animals. RESULTS: At wk 11, four early-invasive adenocarcinomas and 36 dysplasia were found in 10 (90.9%) of the 11 mice that underwent 1,2-dimethylhydrazine-pretreatment with 3 cycles of 30 g/L dextran sulfate sodium-exposure. Dysplasia and/or cancer occurred as flat lesions or as dysplasia-associated lesion or mass (DALM) as observed in humans. Colorectal carcinogenesis occurred primarily on the distal portion of the large intestine. No dysplasia and/or cancer lesion was observed in the control groups with 1,2-dimethylhydrazine pretreatment or 3 cycles of 30 g/L dextran sulfate sodium exposure alone. Immunohistochemical investigation revealed that beta-catenin was translocated from cell membrane to cytoplasm and/or nucleus in 100% of cases with dysplasia and neoplasm, while normal membrane staining was observed in cases without dysplasia and the normal control animals. Nuclear expression of p53 was not detected in specimens. CONCLUSION: A single dose of procarcinogen followed by induction of chronic ulcerative colitis results in a high incidence of colorectal dysplasia and cancer. Abnormal expression of beta-catenin occurs frequently in dysplasia and cancer. This novel mouse model may provide an excellent vehicle for studying colitis-related colon carcinogenesis.
引用
收藏
页码:2958 / 2962
页数:5
相关论文
共 34 条
[1]
Effect of iron supplementation on oxidative stress and intestinal inflammation in rats with acute colitis [J].
Aghdassi, E ;
Carrier, J ;
Cullen, J ;
Tischler, M ;
Allard, JP .
DIGESTIVE DISEASES AND SCIENCES, 2001, 46 (05) :1088-1094
[2]
Inhibitory effects of freeze-dried milk fermented by selected Lactobacillus bulgaricus strains on carcinogenesis induced by 1,2-dimethylhydrazine in rats and by diethylnitrosamine in hamsters [J].
Balansky, R ;
Gyosheva, B ;
Ganchev, G ;
Mircheva, Z ;
Minkova, S ;
Georgiev, G .
CANCER LETTERS, 1999, 147 (1-2) :125-137
[3]
β-Catenin and the morphogenesis of colorectal cancer [J].
Brabletz, T ;
Jung, A ;
Kirchner, T .
VIRCHOWS ARCHIV, 2002, 441 (01) :1-11
[4]
MUTATIONS IN THE P53 GENE - AN EARLY MARKER OF NEOPLASTIC PROGRESSION IN ULCERATIVE-COLITIS [J].
BRENTNALL, TA ;
CRISPIN, DA ;
RABINOVITCH, PS ;
HAGGITT, RC ;
RUBIN, CE ;
STEVENS, AC ;
BURMER, GC .
GASTROENTEROLOGY, 1994, 107 (02) :369-378
[5]
Clapper ML, 1999, ALIMENT PHARM THER, V13, P389
[6]
FACTORS AFFECTING THE OUTCOME OF ENDOSCOPIC SURVEILLANCE FOR CANCER IN ULCERATIVE-COLITIS [J].
CONNELL, WR ;
LENNARDJONES, JE ;
WILLIAMS, CB ;
TALBOT, IC ;
PRICE, AB ;
WILKINSON, KH .
GASTROENTEROLOGY, 1994, 107 (04) :934-944
[7]
COOPER HS, 1993, LAB INVEST, V69, P238
[8]
Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: a study of histopathology, B-catenin and p53 expression and the role of inflammation [J].
Cooper, HS ;
Murthy, S ;
Kido, K ;
Yoshitake, H ;
Flanigan, A .
CARCINOGENESIS, 2000, 21 (04) :757-768
[9]
A decision analysis of surveillance for colorectal cancer in ulcerative colitis [J].
Delcò, F ;
Sonnenberg, A .
GUT, 2000, 46 (04) :500-506
[10]
The risk of colorectal cancer in ulcerative colitis: a meta-analysis [J].
Eaden, JA ;
Abrams, KR ;
Mayberry, JF .
GUT, 2001, 48 (04) :526-535